share_log

HC Wainwright & Co. Reiterates Buy on Zentalis Pharma, Maintains $55 Price Target

Benzinga ·  Aug 10, 2023 06:40

HC Wainwright & Co. analyst Andrew Fein reiterates Zentalis Pharma (NASDAQ:ZNTL) with a Buy and maintains $55 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment